Interim Results from a Phase 1/2 Clinical Study of Lentiglobin Gene Therapy for Severe Sickle Cell Disease

被引:28
作者
Kanter, Julie [1 ]
Walters, Mark C. [2 ]
Hsieh, Matthew M. [3 ]
Krishnamurti, Lakshmanan [4 ,5 ]
Kwiatkowski, Janet [6 ]
Kamble, Rammurti T. [7 ,8 ]
von Kalle, Christof [9 ]
Kuypers, Frans A. [10 ]
Cavazzana, Marina [11 ]
Leboulch, Philippe [12 ,13 ,14 ,15 ,16 ]
Joseney-Antoine, Marcelyne [17 ]
Asmal, Mohammed [17 ]
Thompson, Alexis A. [18 ]
Tisdale, John F. [3 ]
机构
[1] Med Univ S Carolina, Div Pediat, Charleston, SC USA
[2] UCSF Benioff Childrens Hosp Oakland, Oakland, CA USA
[3] NHLBI, Mol & Clin Hematol Branch, NIDDK, NIH, Bethesda, MD USA
[4] Emory Univ, Aflac Canc & Blood Disorders Ctr, Atlanta, GA USA
[5] Childrens Healthcare Atlanta, Atlanta, GA USA
[6] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA USA
[7] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX USA
[8] Houston Methodist Hosp, Houston, TX USA
[9] German Canc Res Ctr, Natl Ctr Tumor Dis NCT, Heidelberg, Germany
[10] Childrens Hosp, Oakland Res Inst, 747 52nd St, Oakland, CA 94609 USA
[11] Grp Hosp Univ Ouest, AP HP, Biotherapy Clin Invest Ctr, INSERM, Paris, France
[12] CEA, Fontenay Aux Roses, France
[13] Univ Paris Sud, Inst Emerging Dis & Innovat Therapies, Fontenay Aux Roses, France
[14] Mahidol Univ, Ramathibodi Hosp, Bangkok, Thailand
[15] Harvard Univ, Sch Med, Boston, MA USA
[16] Brigham & Womens Hosp, Boston, MA USA
[17] Bluebird Bio, Cambridge, MA USA
[18] Ann Robert H Lurie Childrens Hosp Chicago, Div Hematol Oncol Stem Cell Transplant, Chicago, IL USA
关键词
D O I
10.1182/blood.V128.22.1176.1176
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1176
引用
收藏
页数:5
相关论文
empty
未找到相关数据